Collegium Pharmaceutical Inc

Company Snapshot
100 Technology Center Drive
Stoughton, MA 02072
United States
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 207
https://www.collegiumpharma.com
Please select from the dropdown
Company Financials

2020
2021
2022
Gross Profit
$179,836,000
$150,617,000
$209,488,000
Operating Income
$56,232,000
$22,206,000
$33,319,000
Net Income
$26,752,000
$71,517,000
($25,002,000)
2020
Gross Profit
$179,836,000
Operating Income
$56,232,000
Net Income
$26,752,000
2021
Gross Profit
$150,617,000
Operating Income
$22,206,000
Net Income
$71,517,000
2022
Gross Profit
$209,488,000
Operating Income
$33,319,000
Net Income
($25,002,000)
The above data on Collegium Pharmaceutical Inc came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Joseph Ciaffoni
Director, President and Chief Executive Officer
$1,666,134
$5,231,750
$19,646
$6,917,530
Joseph Ciaffoni
$6,917,530
Director, President and Chief Executive Officer
Shirley Kuhlmann
Executive Vice President General Counsel, Secretary and Chief Administrative Officer
$824,274
$1,588,264
$18,624
$2,431,162
Shirley Kuhlmann
$2,431,162
Executive Vice President General Counsel, Secretary and Chief Administrative Officer
Colleen Tupper
Executive Vice President Chief Financial Officer and Principal Accounting Officer
$829,851
$1,470,615
$18,438
$2,318,904
Colleen Tupper
$2,318,904
Executive Vice President Chief Financial Officer and Principal Accounting Officer
Scott Dreyer
Executive Vice President and Chief Commercial Officer
$725,807
$1,470,615
$20,770
$2,217,192
Scott Dreyer
$2,217,192
Executive Vice President and Chief Commercial Officer
Thomas Smith
Executive Vice President and Chief Medical Officer
$599,835
$0
$682
$600,517
Thomas Smith
$600,517
Executive Vice President and Chief Medical Officer
Collegium Pharmaceutical Inc listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2022. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us